New User:
-or-
Username:
Password:
Forgot your password?
News Breaks
October 30, 2009
06:34 EDTALXN
theflyonthewall.com: Alexion Pharma initiated with a Neutral at BofA/Merrill
Target $53. :theflyonthewall.com



News For ALXN From The Last 14 Days
Check below for free stories on ALXN the last two weeks.
There are 12 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing.
February 10, 2012
09:59 EDTALXN
theflyonthewall.com: On The Fly: Analyst Upgrade Summary

Subscribe for More Information :theflyonthewall.com
08:46 EDTALXN
theflyonthewall.com: Alexion target raised to $90 from $76 at ThinkEquity
After Alexion reported stronger than expected Q4 results, ThinkEquity increased its target on the company, based on an increase in the firm's Soliris estimates. The firm maintains a Buy rating on the stock. :theflyonthewall.com
07:26 EDTALXN
theflyonthewall.com: Alexion shares should be bought on strength, says Oppenheimer
After Alexion reported stronger than expected Q4 results, Oppenheimer believes that the company's 2012 guidance is conservative. The firm expects the stock to advance further on continued Soliris sales growth and increasing visibility on new Soliris indications.. :theflyonthewall.com
07:23 EDTALXN
theflyonthewall.com: Alexion price target raised to $96 from $80 at Leerink
Leerink raised its estimates and price target for Alexion following the company's Q4 results and keeps an Outperform rating on the stock. :theflyonthewall.com
06:28 EDTALXN
theflyonthewall.com: Alexion upgraded to Outperform from Neutral at RW Baird

Subscribe for More Information :theflyonthewall.com

February 9, 2012
10:27 EDTALXN
theflyonthewall.com: Alexion sees one-time GAAP tax charge in FY12 of $80M-$100M
:theflyonthewall.com
10:26 EDTALXN
theflyonthewall.com: Alexion sees Q4 to Q1 revenue growth occuring at a somewhat slower rate

Subscribe for More Information :theflyonthewall.com
06:49 EDTALXN
theflyonthewall.com: Alexion sees FY12 EPS $1.60-$1.70 vs. consensus $1.67

Subscribe for More Information :theflyonthewall.com
06:46 EDTALXN
theflyonthewall.com: Alexion reports Q4 EPS 41c vs. consensus 34c

Subscribe for More Information :theflyonthewall.com

February 3, 2012
10:30 EDTALXN
theflyonthewall.com: On The Fly: Analyst Upgrade Summary

Subscribe for More Information :theflyonthewall.com
06:20 EDTALXN
theflyonthewall.com: Alexion upgraded to Conviction Buy from Buy at Goldman

Subscribe for More Information :theflyonthewall.com

January 31, 2012
11:21 EDTALXN
theflyonthewall.com: Piper Jaffray's biotech and specialty pharma analysts hold a conference call

Subscribe for More Information :theflyonthewall.com